1. Home
  2. SCLX vs AMTD Comparison

SCLX vs AMTD Comparison

Compare SCLX & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.03

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

HOLD

Current Price

$1.00

Market Cap

78.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
AMTD
Founded
2011
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
78.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SCLX
AMTD
Price
$9.03
$1.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
80.8K
25.4K
Earning Date
11-14-2025
12-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$119,304,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$1.25
Revenue Growth
N/A
154.24
52 Week Low
$3.60
$0.87
52 Week High
$34.27
$1.65

Technical Indicators

Market Signals
Indicator
SCLX
AMTD
Relative Strength Index (RSI) 34.71 48.07
Support Level $7.82 $0.96
Resistance Level $10.41 $1.01
Average True Range (ATR) 1.02 0.03
MACD 0.05 0.00
Stochastic Oscillator 20.56 56.76

Price Performance

Historical Comparison
SCLX
AMTD

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

Share on Social Networks: